Validations: PPQ/CPV Strategy for Biosimilars
Outlier Rules That Don’t Break Similarity Logic Outlier Rules That Don’t Break Similarity Logic Introduction to Biosimilar Analytical Comparability The increasing complexity of biologics and the need for cost-effective alternatives have led to the development of biosimilars. The U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have laid out guidelines for establishing analytical comparability. These guidelines…
Continuous Manufacturing in Biosimilars: CPV Implications Continuous Manufacturing in Biosimilars: CPV Implications 1. Introduction to Continuous Manufacturing in Biosimilars Continuous manufacturing has emerged as a transformative technology in the pharmaceutical industry, particularly in the production of biosimilars. This innovative approach allows for a more streamlined and efficient manufacturing process that adheres to current Good Manufacturing Practices (cGMP). It presents unique…
Sampling for Rare Events in Biosimilars Sampling for Rare Events in Biosimilars In the rapidly advancing field of biosimilars, maintaining regulatory compliance while ensuring product quality is paramount. This step-by-step guide aims to provide pharmaceutical professionals with a comprehensive understanding of the methodologies and strategies needed to effectively sample for rare events in biosimilars, specifically focusing on PPQ (Process Performance…
Ongoing Verification During Post-Approval Changes Ongoing Verification During Post-Approval Changes In the rapidly evolving world of biosimilars, ensuring that post-approval changes maintain product quality is critical. This article provides a comprehensive step-by-step tutorial on the ongoing verification processes necessary for effective biosimilar analytical comparability, focusing on strategy elements such as CQA mapping, fingerprint analytics, and process drift monitoring. Step 1:…
Acceptance Criteria for PPQ: Attribute vs Variable In the evolving landscape of biosimilars, the need for robust validation methodologies is paramount. The Process Performance Qualification (PPQ) serves as a crucial step in ensuring product quality consistency and regulatory compliance. This article presents a comprehensive step-by-step tutorial on how to establish acceptance criteria for PPQ while contrasting attributes against variables. We…
Leveraging Prior Knowledge: Development Data to PPQ Introduction to PPQ for Biosimilars Process Performance Qualification (PPQ) is a crucial component of the lifecycle of biosimilars, ensuring that the manufacturing processes yield products that meet specified criteria for quality and efficacy. In today’s regulatory landscape under the FDA, EMA, MHRA, and PIC/S, effective implementation of PPQ is paramount for regulatory approval…
Equivalence in PPQ: What Is Defensible Equivalence in PPQ: What Is Defensible The biopharmaceutical industry continually encounters challenges in demonstrating analytical comparability, especially for biosimilars. To ensure regulatory compliance and the successful approval of biosimilars, understanding the principles of Process Performance Qualification (PPQ) and its relationship to equivalence testing is fundamental. This article serves as a step-by-step tutorial for pharma…
CPV Tailoring for Biosimilars: Signals and Windows CPV Tailoring for Biosimilars: Signals and Windows The pharmaceutical industry faces unique challenges when developing biosimilars, particularly concerning keeping regulatory compliance while demonstrating analytical comparability. A comprehensive understanding of the Process Performance Qualification (PPQ) and Continued Process Verification (CPV) strategy is crucial to navigate the complexities of equivalence testing, Critical Quality Attribute (CQA)…
Short-Run SPC for PPQ and Early CPV This article serves as a comprehensive guide for professionals in the pharmaceutical industry focusing on the development and validation of biosimilars. It elaborates on the pivotal aspects of Process Performance Qualification (PPQ) and Continuous Process Verification (CPV), particularly emphasizing CQA mapping and fingerprint analytics. This guide is designed to equip you with a…
PPQ Strategy in Biosimilars: How Many Lots and Why In the context of biosimilars, the Product Process Qualification (PPQ) strategy plays a crucial role in ensuring that the biosimilar product is comparable to its reference product. This tutorial provides a step-by-step guide to understanding the PPQ strategy in biosimilars, addressing critical aspects such as lot selection, analytical comparability, CQA mapping,…